Reconstructed implantation and placentation
Understanding and rebuilding the embryo-uterus interface - implantation, trophoblast invasion, placental exchange and immune tolerance - outside a body.
State of the art
Optimized ex utero culture supported mouse embryos from embryonic day 6.5/7.5 to about day 12.5 (2026), extending the 2021 Nature platform; human embryo culture is capped at about 14 days by the research limit adopted in many jurisdictions.
- The placenta's endocrine and nutrient-exchange functions have not been reproduced by any device or culture
- Maternal immune tolerance at the interface is not understood well enough to substitute for
- Human implantation cannot be studied past the 14-day limit, so the critical window is inaccessible
Who’s working on it
- Jacob HannaResearcherWeizmann Institute of Science
Built the ex utero mouse embryo culture platform (Nature, 2021) that the 2026 extension into the fetal period is based on
- Nicolas RivronResearcherInstitute of Molecular Biotechnology, Austrian Academy of Sciences
Makes human blastoids that attach to hormonally primed endometrial organoids, and used the assay to screen compounds that block implantation
- Ashley MoffettResearcherUniversity of Cambridge
Showed uterine natural killer cells control extravillous trophoblast differentiation in early pregnancy (Cell Stem Cell, 2024), the core of maternal immune tolerance
- Centre for Trophoblast Research ↗Academic lab
Cambridge centre supplying the trophoblast organoid and placental-interface biology the rest of the field builds on
- Human Developmental Biology ResourceProgram
UK tissue resource that enabled the single-cell atlas of the maternal-fetal interface and is the main legal source of early human implantation-stage material
- International Society for Stem Cell ResearchProgram
Its 2021 guidelines moved extended embryo culture past 14 days from prohibited to case-by-case review, the lever that would open the blocking window
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Stem-cell-derived implantation models and perfused endometrium-on-chip systems benchmarked against primate in vivo data | $$ $10M – $100M |
| policy | Deliberate revisiting of the 14-day rule with defined oversight, since the window it closes is the blocking unknown | $ < $10M |
Depends on
A root node: no prerequisites modeled.